Modified drug combination may reduce risk of recurrence for some breast cancer patients
Masey Ross, M.D., and Charles Geyer, Jr., M.D. Credit: VCU Massey Cancer Center Oncologists at VCU Massey Cancer Center were invited to co-author [...]
Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. [...]
Researchers develop model to personalize radiation treatment
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types [...]
Patient preferences explored in multiple myeloma treatment
(HealthDay)—An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment satisfaction in patients with relapsed or refractory multiple myeloma (RRMM), [...]
Many clinical trials for new cancer drugs didn’t include any data on race
One-third of the clinical trials that led to new cancer drugs approved between 2008 and 2018 didn’t report on the race of trial participants — [...]
Drug May Aid People With Advanced Thyroid Cancer
MONDAY, Aug. 13 (HealthDay News) -- A new study shows that the chemotherapy drug vandetanib (Caprelsa) may extend life a bit for some thyroid cancer patients. The results of [...]
How Amgen plans to BiTE into CAR-T’s hype
While personalized CAR-T cancer therapies make headlines in biotech, Amgen has been betting big on another tumor-killing approach with, yes, another acronym: BiTEs. The trademarked term [...]
When the cardiology patient ends up in the oncology care ward
New research shows what can happen with patients in 'off-service' hospital beds. If you end up needing to go to the hospital, often times you're [...]
Study finds lack of racial diversity in cancer drug clinical trials
New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study—conducted by researchers [...]
New drug shows encouraging survival in pancreatic cancer
A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. A [...]
